INTRODUCTION
The recent development of gene transfer systems for mycobacteria has provided an important new tool for analysis of mechanisms of drug resistance and for generation of novel recombinant vaccines (Aldovini & Young, 1991 ; Stover etal., 1991 ; Zhang etal., 1993) . The most commonly used systems employ plasmid vectors carrying the origin of replication from a naturally occurring mycobacterial plasmid, pAL5000 (Labidi e t a/., 1985 (Labidi e t a/., , 1992 , or the chromosomal attachment site from mpcobacteriophage L5 (Lee e t al., 1991) (Snapper e t al., 1990) .
We were interested in transforming additional mycobacterial species. In particular, we wished to explore the possibility of using _iLl_cobacteriam w (Talwar, 1978) and Mycobacterizmt vaccae (Stanford e t al. , 1990) (Garbe e t al., 1993; Zhang e t al., 1991) , and we were interested in exploring the potential for using other non-pathogenic mycobacteria in a similar role.
In initial experiments we were unable to demonstrate transformation of these mycobacterial species using previously described vectors employing kanamycin re-IP: 54.70.40.11
On: Thu, 04 Apr 2019 00:51:10 T. R. G A R B E a n d O T H E R S Narl ALori I 1.9 kb deletion I Deletionhearrangement pBSH5 (unable to replicate in E. coli) Fig. 7 . Vector construction. p16R1 was generated by insertion of a 2.6 kb fragment derived from pYUB12 and containing the origin of replication from mycobacterial plasmid pAL5000 ('ALori') into the unique BarnHl site in plJ963. Analysis of the resulting plasmid revealed a deletion of a 1.9 kb fragment including the AmpR region of pIJ963. pBSH5 was generated by insertion of a 1.75 kb fragment containing HygR from plJ963 into the BarnHl site in pYZ5. The resulting plasmid was unable to replicate in E. coli, and is assumed to have undergone deletion and/or rearrangement.
sistance as a selectable marker. In this report we describe the general utility of hygromycin resistance as a selectable marker for several mycobacterial strains, and demonstrate the application of a novel hygromycin resistance vector for overexpression of the superoxide dismutase enzyme from Mycobacteriam tnbercdosis.
METHODS

Bacterial cultures and electroporation. For electroporation
experiments, all of the mycobacteria were grown in Middlebrook 7H9 medium supplemented with albumin, dextrose and catalase (ADC), according to the manufacturer's recommendations (Difco). Mycobacterium w (Talwar, 1978) was grown as standing cultures at 37 "C; M . vaccae (kindly supplied by D r J o h n Stanford, University College and Middlesex Hospital School of Medicine, London) was grown with shaking at 30 "C ; M. smegmatis 1-2c (a derivative of strain mc26 selected for improved transformation efficiency) (Zhang P t al., 1991) and M. bovis BCG (Glaxo strain) were grown in shaking cultures at 37 "C.
For electroporation experiments, cultures (200 ml) with an AGO,, of 0.5-1-0 were processed as described previously by chilling on ice and washing with glycerol (Zhang e t al., 1991) . Bacterial suspensions in glycerol (0-1-0-4 ml) were mixed with plasmid DNA (in 1-5 pl deionized water) and subjected to electroporation using a Bio-Rad Gene Pulser as previously described (Zhang e t al., 1791) . Cold 7H9/ADC medium (0-4-0.5 ml) was added and, after incubation for 2-4 h to allow phenotypic expression, aliquots (0.1-0-2 ml) were spread on agar plates prepared using Middlebrook 7H11 medium supplemented with oleic acid, albumin, dextrose, catalase (OADC ; Difco) and appropriate antibiotics. Kanamycin sulphate (Sigma) was used at a concentration of 50 pg ml-'. Hygromycin B (Sigma) was supplied in solution (460000 units ml-', with one unit corresponding to 455 ng) and was used at 50 pg ml-' for myco- Escherichia coli shuttle vector, pBAK14, has been described previously, along with pYZ5, a pBAK14 derivative containing the M. tuberczthis sodA gene on a 1.1 kb EcoRT-KpnI fragment (Zhang et al., 1991) . Two additional mycobacterial shuttle vectors -pYUB12 (Snapper etal., 1988) resistance gene (Lyg) from Streptomyces bygroscopiczts (Lydiate et al., 1989) . A shuttle plasmid encoding hygromycin resistance, pl6R1, was prepared by cutting at the unique BamHI site of pIJ963, filling in the ends with DNA polymerase I (Klenow fragment), and ligation of a 2.59 kb EcoRV-HpaI fragment derived from pYUB12 which contained the origin of replication of the mycobacterial plasmid pAL5000 (Ranes e t aL, 1990) (Fig.   1 ). The ligation mixture was used to transform 211. smegmatis by electroporation selecting for hygromycin resistance. Plasmid DNA was prepared from M. smegmatis transformants grown in the presence of 1 YO (v/v) glycine using standard procedures (Sambrook e t al., 1989) and used to transform E. coli JM105.
As an alternative approach to generation of a shuttle plasmid encoding hygromycin resistance, the hyg gene from PI 5963 was excised as a 1.75 kb BgGlI fragment and ligated into the BamHI site of pYZ5 (Zhang etal., 1991) . The ligation mixture was used to transform M. uaccae and a plasmid, pBSH.5, was isolated after selection for hygromycin resistance.
The characteristics of plasmids used in this study are listed in Table 1 . (Zhang etal., 1991) . For SDS-PAGE samples (10-20 pg protein)
were treated with sample buffer containing SDS and pmercaptoethanol and separated in discontinuous gels containing 1 2 % (w/v) acrylamide as described by Laemmli (1970) . Gels were then stained with Coomassie Brilliant blue or transferred to nitrocellulose membranes for Western blot analysis (Towbin etaL., 1979) . Blots were then stained with a monoclonal antibody (D2D) against mycobacterial superoxide dismutase as described previously (Zhang e t al., 1991) . The electrophoretic mobility of recombinant superoxide dismutase enzymes was examined by IP: 54.70.40.11
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RESULTS
Construction of plasmid vectors containing the hyg gene
Two strategies were adopted for construction of shuttle vectors containing the hygromycin resistance gene along with a mycobacterial origin of replication. In the first approach, a fragment containing the replication origin of the cryptic mycobacterial plasmid pAL5000 was inserted into the hygromycin-resistance-expressing plasmid PI 5963 and the ligation mixture transformed directly into M. smegmatis. Two transformed colonies were examined in detail. From one (16R1) a plasmid conferring hygromycin resistance could be recovered and propagated in E. coli when selected for Hyg'. Further analysis of the plasmid (pl6R1) revealed that a 1.9 kb deletion including the AmpR region of the pUC component had occurred (Fig. 1) . Plasmid DNA isolated from the second colony (1 6R2) was capable of retransforming M. smegmatis, but failed to transform E. coli. We infer that a deletion or a rearrangement had also occurred in this plasmid, and no further characterization was attempted.
The second strategy was to ligate a DNA fragment containing the byg gene into a previously characterized mycobacterial shuttle plasmid, pYZ5 (Zhang e t al., 1991) (Fig. 1) . In this case, the ligation mixture was used to transform M. vaccae. As had been found for 16R2 above, plasmids isolated from transformants could not be transformed into E. coli (Hygr selection), although successful retransformation of M . vaccae was readily demonstrated.
Again, we infer that alterations in the plasmid had resulted in loss of the E. coli origin of replication.
Transformation efficiency with hyg vectors
The shuttle plasmid pl6Rl (iyg) was tested for its ability to transform several mycobacterial species, and compared with pBAK14, a shuttle vector with a kanamycin resistance determinant. In each of the four species tested, the number of transformants obtained after electroporation with pl6Rl was greater than that obtained with the same amount of pBAK14 DNA ( Table 2) . The difference was particularly pronounced in the case of M.
vaccae and Mjcabacteritlm w. We were unable to demonstrate transformation in either of these species using k m vectors (pBAK14, pYUB12 and pMV251), whereas the iyg vector consistently yielded 103-105 transformants (pg DNA)-'.
Even with M. bovis BCG and M . smegmatis, which were previously shown to be transformable with kan vectors, transformation frequencies with pl6R1 were greater than those observed with pBAK14. We also noted a difference in the rate of growth of the two types of transformants.
pl6R1 transformants of M. smeg7nati.r emerged on the Hyg plates 1-2 d before pBAK14 transformants appeared on Kan plates. Similarly, a difference of up to 1 week was noted for M . bovis BCG transformants. In each case, drugresistant colonies were presumed to be genuine transformants since: (a) there was little or no spontaneous drug resistance in controls without DNA; (b) each time an individual resistant colony was tested, it was found to contain plasmid DNA; and (c) similarly, each colony tested was found to express the expected recombinant proteins (see below).
Expression of M. tuberculosis superoxide dismutase in different mycobacteria
We then investigated the use of hyg vectors for expression of a heterologous protein in different mycobacterial species. Superoxide dismutase from M. tzlberczllosis was selected as a 'model' protein for these experiments. We have previously demonstrated the introduction of the recombinant sodA gene into M . smegmatis where, in contrast to E. cali, it is expressed in a functionally active form (Zhang e t al., 1991) . pBSH5, generated by introduction of the byg gene into a shuttle vector already carrying the sodA gene (Fig. l) , was used to transform M. (Fig. 3) . Expression of M . tzrbercdosis sodA in M . smegmatis results in the generation of five presumably hybrid tetrameric enzymes formed by combination of subunits between the host and the plasmid-specified superoxide dismutases. In contrast, in M. vaccae, the predominant superoxide dismutase band in the recombinant strain has a migration pattern identical to that of the native M . tzherczllosis enzyme. The pattern of recombinant superoxide dismutase expression in Mycobacterizlm w resembled that seen in M . smegmatis.
DISCUSSION
Our results indicate that selection on the basis of hygromycin resistance may have certain advantages over the use of kanamycin resistance in mycobacterial transformation experiments. This is particularly true in experiments using mycobacterial species other than laboratory strains of M. smegmatis and M . bovis BCG. We have previously reported the difficulties in transforming clinical isolates of M . tzrberczllosis (Zhang e t al., 1992 ) and we have recently been able to overcome these difficulties using the pl6Rl vector (Zhang e t al., 1993) . The reason for the improved transformation frequency offered by hygromycin selection has not been elucidated. The fact that two different byg vectors (pl6R1 and pBSH5) can transform M . vaccae and Mycobacterizrm w, whilst three kan vectors (pBAK14, pYUB12 and pMV251) were unsuccessful, tends to suggest that it is the drug selection itself which is important, rather than some other property of the particular vector. The byg resistance gene from Streptomyces bygroscopiczls may be more efficiently expressed in mycobacteria than the E. coli-derived aminoglycoside phosphotransferase gene involved in kanamycin resistance. However, it is important to note that the byg vectors were prepared by electroporation of ligation mixtures directly into mycobacterial recipients, and it is possible that subsequent recombination events may have conferred enhanced stability of these plasmids in mycobacterial hosts. In addition to broadening the potential host range for mycobacterial transformation, hygromycin resistance is attractive in providing a second selectable marker for genetic experiments in mycobacteria, and in providing a resistance marker which avoids use of a clinically applicable drug.
M. smegmatis is a useful model system for mycobacterial genetic experiments because of its ease of laboratory manipulation in terms of lack of pathogenicity and relatively rapid growth rate. However, other mycobacterial species may provide more useful models for studying some specific aspects of mycobacterial physiology or biochemistry. Thus we have demonstrated a role for M . vaccae as a host for overexpression of M . tzlberczrlosis superoxide dismutase. Whilst transformation with Ad.
tzrberczdosis sodA generates hybrid enzymes in M. smegmatis (Zhang e t al., 1991) , the M. z'accae expression system allows us to obtain the recombinant superoxide dismutase apparently in the native form. This system is currently being used to produce large amounts of the enzyme (10 mg purified protein per litre of culture) for structural studies (Cooper e t al., 1994) .
Mycobacterizrm w has been administered as an immunotherapeutic agent to patients undergoing treatment for lepromatous leprosy and is currently undergoing clinical trials as a prophylactic anti-leprosy vaccine (Talwar e t al., 1990; Zaheer e t dl., 1993) . M. vacme has been used as a vaccine in a series of human trials and is currently being tested for efficacy in immunotherapy of tuberculosis (Stanford e t al., 1990) . In contrast to 12.1. bovis BCG, both of these mycobacteria are administered as killed vaccine preparations. The known adjuvant properties of mycobacteria make it attractive to suggest that Mjcobacterimz w and M. vaccae could be used as carriers to deliver heterologous antigens to the immune system; either by mixing purified antigens with existing vaccines, or by taking advantage of recombinant DNA techniques to achieve expression of the antigens in mycobacterial cells. The techniques developed in this study provide a means for pursuing such an objective.
